Literature DB >> 20106931

The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling.

Maudry Laurent-Rolle1, Elena F Boer, Kirk J Lubick, James B Wolfinbarger, Aaron B Carmody, Barry Rockx, Wenjun Liu, Joseph Ashour, W Lesley Shupert, Michael R Holbrook, Alan D Barrett, Peter W Mason, Marshall E Bloom, Adolfo García-Sastre, Alexander A Khromykh, Sonja M Best.   

Abstract

Flaviviruses transmitted by arthropods represent a tremendous disease burden for humans, causing millions of infections annually. All vector-borne flaviviruses studied to date suppress host innate responses to infection by inhibiting alpha/beta interferon (IFN-alpha/beta)-mediated JAK-STAT signal transduction. The viral nonstructural protein NS5 of some flaviviruses functions as the major IFN antagonist, associated with inhibition of IFN-dependent STAT1 phosphorylation (pY-STAT1) or with STAT2 degradation. West Nile virus (WNV) infection prevents pY-STAT1 although a role for WNV NS5 in IFN antagonism has not been fully explored. Here, we report that NS5 from the virulent NY99 strain of WNV prevented pY-STAT1 accumulation, suppressed IFN-dependent gene expression, and rescued the growth of a highly IFN-sensitive virus (Newcastle disease virus) in the presence of IFN, suggesting that this protein can function as an efficient IFN antagonist. In contrast, NS5 from Kunjin virus (KUN), a naturally attenuated subtype of WNV, was a poor suppressor of pY-STAT1. Mutation of a single residue in KUN NS5 to the analogous residue in WNV-NY99 NS5 (S653F) rendered KUN NS5 an efficient inhibitor of pY-STAT1. Incorporation of this mutation into recombinant KUN resulted in 30-fold greater inhibition of JAK-STAT signaling than with the wild-type virus and enhanced KUN replication in the presence of IFN. Thus, a naturally occurring mutation is associated with the function of NS5 in IFN antagonism and may influence virulence of WNV field isolates.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20106931      PMCID: PMC2838099          DOI: 10.1128/JVI.01161-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

Review 1.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

2.  The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner.

Authors:  Sven Miller; Stefan Kastner; Jacomine Krijnse-Locker; Sandra Bühler; Ralf Bartenschlager
Journal:  J Biol Chem       Date:  2007-02-02       Impact factor: 5.157

3.  Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins.

Authors:  Wen Jun Liu; Xiang Ju Wang; Vladislav V Mokhonov; Pei-Yong Shi; Richard Randall; Alexander A Khromykh
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression.

Authors:  Meleri Jones; Andrew Davidson; Linda Hibbert; Petra Gruenwald; Joerg Schlaak; Simon Ball; Graham R Foster; Michael Jacobs
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell.

Authors:  Ling-Jun Ho; Li-Feng Hung; Chun-Yi Weng; Wan-Lin Wu; Ping Chou; Yi-Ling Lin; Deh-Ming Chang; Tong-Yuan Tai; Jenn-Haung Lai
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

6.  Crystal structure of the RNA polymerase domain of the West Nile virus non-structural protein 5.

Authors:  Hélène Malet; Marie-Pierre Egloff; Barbara Selisko; Rebecca E Butcher; Peter J Wright; Michael Roberts; Arnaud Gruez; Gerlind Sulzenbacher; Clemens Vonrhein; Gérard Bricogne; Jason M Mackenzie; Alexander A Khromykh; Andrew D Davidson; Bruno Canard
Journal:  J Biol Chem       Date:  2007-02-07       Impact factor: 5.157

7.  Identification of residues critical for the interferon antagonist function of Langat virus NS5 reveals a role for the RNA-dependent RNA polymerase domain.

Authors:  Gregory S Park; Keely L Morris; Roselyn G Hallett; Marshall E Bloom; Sonja M Best
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

8.  Cholesterol manipulation by West Nile virus perturbs the cellular immune response.

Authors:  Jason M Mackenzie; Alexander A Khromykh; Robert G Parton
Journal:  Cell Host Microbe       Date:  2007-10-11       Impact factor: 21.023

9.  West Nile virus envelope protein inhibits dsRNA-induced innate immune responses.

Authors:  Alvaro Arjona; Michel Ledizet; Karen Anthony; Nathalie Bonafé; Yorgo Modis; Terrence Town; Erol Fikrig
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

10.  Genome sequence and attenuating mutations in West Nile virus isolate from Mexico.

Authors:  David W C Beasley; C Todd Davis; Jose Estrada-Franco; Roberto Navarro-Lopez; Arturo Campomanes-Cortes; Robert B Tesh; Scott C Weaver; Alan D T Barrett
Journal:  Emerg Infect Dis       Date:  2004-12       Impact factor: 6.883

View more
  127 in total

1.  Two distinct sets of NS2A molecules are responsible for dengue virus RNA synthesis and virion assembly.

Authors:  Xuping Xie; Jing Zou; Chunya Puttikhunt; Zhiming Yuan; Pei-Yong Shi
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  A single amino acid in nonstructural protein NS4B confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis.

Authors:  Dixon Grant; Grace K Tan; Min Qing; Jowin K W Ng; Andy Yip; Gang Zou; Xuping Xie; Zhiming Yuan; Mark J Schreiber; Wouter Schul; Pei-Yong Shi; Sylvie Alonso
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

3.  Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells.

Authors:  Joanna A Pulit-Penaloza; Svetlana V Scherbik; Margo A Brinton
Journal:  Virology       Date:  2012-02-03       Impact factor: 3.616

4.  West Nile virus infection induces depletion of IFNAR1 protein levels.

Authors:  Jared D Evans; Rachel A Crown; Ji A Sohn; Christoph Seeger
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

Review 5.  The innate immune playbook for restricting West Nile virus infection.

Authors:  Kendra M Quicke; Mehul S Suthar
Journal:  Viruses       Date:  2013-10-30       Impact factor: 5.048

6.  Adaptive Diversification Between Yellow Fever Virus West African and South American Lineages: A Genome-Wide Study.

Authors:  Yan Li; Zexiao Yang
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

Review 7.  Innate antiviral immune signaling, viral evasion and modulation by HIV-1.

Authors:  Arjun Rustagi; Michael Gale
Journal:  J Mol Biol       Date:  2013-12-08       Impact factor: 5.469

Review 8.  West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Michael S Diamond; Michael Gale
Journal:  Nat Rev Microbiol       Date:  2013-02       Impact factor: 60.633

9.  3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation.

Authors:  Yijun Du; Jingshan Bi; Jiyu Liu; Xing Liu; Xiangju Wu; Ping Jiang; Dongwan Yoo; Yongguang Zhang; Jiaqiang Wu; Renzhong Wan; Xiaomin Zhao; Lihui Guo; Wenbo Sun; Xiaoyan Cong; Lei Chen; Jinbao Wang
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

10.  Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression.

Authors:  Kirk J Lubick; Shelly J Robertson; Kristin L McNally; Brett A Freedman; Angela L Rasmussen; R Travis Taylor; Avram D Walts; Seitaro Tsuruda; Mizuki Sakai; Mariko Ishizuka; Elena F Boer; Erin C Foster; Abhilash I Chiramel; Conrad B Addison; Richard Green; Daniel L Kastner; Michael G Katze; Steven M Holland; Antonella Forlino; Alexandra F Freeman; Manfred Boehm; Kentaro Yoshii; Sonja M Best
Journal:  Cell Host Microbe       Date:  2015-07-08       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.